To test whether GIFT4-induced STAT5/JAK signaling contributes to the cellular function of GIFT4-CLL cells on the production of immune stimulatory molecules, we used the same inhibitors to suppress JAK1, JAK2 and JAK3 signaling in the cell culture system respectively. The gene discussed is JAK1; the disease is B-cell chronic lymphocytic leukemia.